Explore 3 Stock Ideas & Industry Insights Download Free Report

Agilent Technologies Inc.

Company price
177.8 GBX 2.49 ( 1.42%)
Last update at 2026-10-27T16:46:00Z
VOLUME
310
Market Cap
3645756.62M
P/E
0.28

Momentum Score

…

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
169.20
Low
180.42
High
52 Week Price Range
60.92
Low
161.26
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
175.31
Dividend Yield
0.87%
Revenue TTM
7065.00M
Revenue Per Share
24.92
Gross Profit TTM
3695.00M
Debt / Equity
0.55
ROE
19.95%
Net Debt
1899.00M
ROCE
4.27%
Diluted EPS TTM
4.14

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Type yearly yearly yearly yearly yearly
Date 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Income before tax 442.00M 1521.00M 1339.00M 1504.00M 1360.00M
Net income 434.00M 1289.00M 1240.00M 1254.00M 1210.00M
Selling general administrative - 1469.00M - - 1619.00M
Selling and marketing expenses - 49.00M - - -
Gross profit 990.00M 3559.00M 3465.00M 3722.00M 3407.00M
Ebit 443.00M 1617.00M 1350.00M 1677.00M 1404.00M
Ebitda 731.00M 1874.00M 1621.00M 1994.00M 1725.00M
Depreciation and amortization 288.00M 257.00M 271.00M 317.00M 321.00M
Operating income 443.00M 1593.00M 1350.00M 1677.00M 1404.00M
Other operating expenses 1418.00M 4917.00M 5450.00M 5269.00M 4880.00M
Interest expense 27.00M 96.00M - - 0.00M
Tax provision - - - - 150.00M
Interest income - - - - 79.00M
Income tax expense 8.00M 232.00M 99.00M 250.00M 150.00M
Total revenue 1861.00M 6510.00M 6833.00M 6848.00M 6319.00M
Total operating expenses 547.00M 1966.00M 2082.00M 2143.00M 1968.00M
Cost of revenue 871.00M 2951.00M 3368.00M 3126.00M 2912.00M
Total other income expense net -1.00M -72.00M -11.00M -173.00M -44.00M
Net income applicable to common shares - - - 1254.00M 1210.00M
Breakdown 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Type yearly yearly yearly yearly yearly
Date 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Total assets 12727.00M 11931.00M 10763.00M 10532.00M 10705.00M
Intangible assets 445.00M 547.00M 475.00M 821.00M 981.00M
Other current assets 293.00M 187.00M 274.00M 282.00M 222.00M
Total liab 5986.00M 6033.00M 4918.00M 5227.00M 5316.00M
Total stockholder equity 6741.00M 5898.00M 5845.00M 5305.00M 5389.00M
Other current liab 805.00M 682.00M 1185.00M 1281.00M 1262.00M
Common stock 3.00M 3.00M 3.00M 3.00M 3.00M
Retained earnings 1389.00M 750.00M 782.00M 324.00M 348.00M
Other liab - - - 633.00M 749.00M
Good will 4473.00M 4477.00M 3960.00M 3952.00M 3975.00M
Other assets - - 708.00M 536.00M 642.00M
Cash 1789.00M 1329.00M 1590.00M 1053.00M 1484.00M
Total current liabilities 2347.00M 1895.00M 1603.00M 1861.00M 1708.00M
Current deferred revenue 624.00M 544.00M - - -
Net debt 1899.00M 2287.00M -1590.00M -1053.00M -1484.00M
Short term debt 348.00M 129.00M - - -
Short long term debt total 3688.00M 3616.00M - - 2729.00M
Other stockholder equity 5575.00M 5450.00M 5060.00M 4978.00M 5038.00M
Property plant equipment - - - 1100.00M 1123.00M
Total current assets 4594.00M 3959.00M 4186.00M 3778.00M 3799.00M
Net tangible assets - - - 516.00M 433.00M
Short term investments - - - - 91.00M
Net receivables 1487.00M 1471.00M 1291.00M 1405.00M 1172.00M
Long term debt - - - - 2729.00M
Inventory 1025.00M 972.00M 1031.00M 1038.00M 830.00M
Accounts payable 570.00M 540.00M 418.00M 580.00M 446.00M
Accumulated other comprehensive income -226.00M -305.00M - - -
Non currrent assets other 1059.00M 376.00M -5869.00M -6218.00M -6264.00M
Non current assets total 8133.00M 7972.00M 5869.00M 6218.00M 6264.00M
Breakdown 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Type yearly yearly yearly yearly yearly
Date 2025-10-31 2024-10-31 2023-10-31 2022-10-31 2021-10-31
Investments - - - 9.00M -10.00M
Change to liabilities - - - 121.00M 64.00M
Total cashflows from investing activities -394.00M -1258.00M - -338.00M -749.00M
Net borrowings - - - 26.00M 356.00M
Total cash from financing activities -715.00M -752.00M -930.00M -1372.00M -696.00M
Change to operating activities - - - -30.00M 98.00M
Net income 434.00M 1289.00M 1240.00M 1254.00M 1210.00M
Change in cash 459.00M -261.00M 537.00M -434.00M 43.00M
Begin period cash flow 1332.00M 1590.00M 1056.00M 1490.00M 1447.00M
End period cash flow 1791.00M 1329.00M 1593.00M 1056.00M 1490.00M
Total cash from operating activities 1559.00M 1751.00M 1772.00M 1312.00M 1485.00M
Depreciation 288.00M 257.00M 271.00M 317.00M 321.00M
Other cashflows from investing activities -406.00M -13.00M - -4.00M -5.00M
Dividends paid 282.00M 274.00M 265.00M 250.00M 236.00M
Change to inventory 45.00M 34.00M -33.00M -248.00M -136.00M
Change to account receivables -149.00M 7.00M 132.00M -321.00M -128.00M
Sale purchase of stock -425.00M -1153.00M -629.00M -1206.00M -864.00M
Other cashflows from financing activities -39.00M -30.00M -36.00M 693.00M 821.00M
Change to netincome - - - 219.00M 56.00M
Capital expenditures 407.00M 378.00M 298.00M 291.00M 188.00M
Change in working capital -58.00M 83.00M 99.00M -569.00M -264.00M
Stock based compensation 128.00M - 111.00M 126.00M 111.00M
Other non cash items 897.00M 186.00M 51.00M 184.00M 107.00M
Free cash flow 1152.00M 1373.00M 1474.00M 1021.00M 1297.00M

Peer Comparison*

Sector: Industry:

Stock Name
Change
(GBX)
Price
(GBX)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
0HAV
Agilent Technologies Inc.
2.49
1.42%
177.80 0.28 - 5.16 -
0R15
SoftBank Group Corp.
248.00
5.84%
4494.00 - - - -
0R1E
Nintendo Co. Ltd.
-115.00
1.34%
8476.00 - - - -
0LC3
Synchrony Financial
2.34
3.20%
75.60 0.09 - 4.97 -
0HQP
CBRE Group Inc. Cl A
0.15
0.12%
122.47 0.25 - 1.18 -

Profile*

Agilent Technologies Inc.

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates through three segments: Life Sciences and Diagnostics Markets, Agilent CrossLab, and Applied Markets. The Life Sciences and Diagnostics Markets segment offers liquid chromatography systems and components; and liquid chromatography mass spectrometry systems. This segment is also involved in the genomics, contract development and manufacturing organization, pathology, companion diagnostics, and biomolecular analysis businesses. The Agilent CrossLab segment provides various services, including repairs, parts, maintenance, installations, training, compliance support, software as a service, asset management, consulting, and other custom services. This segment also offers consumables, including gas chromatography and liquid chromatography columns, sample preparation products, custom chemistries, and various laboratory supplies; software and informatics solutions comprising software for instrument control, data acquisition, data analysis, secure storage of results, and laboratory information and workflow management; and OpenLab laboratory software, an open software platform that enables customers to capture, analyze, and share scientific data throughout the lab and across the enterprise. In addition, it provides automated sample preparation solutions, such as liquid handling, plate management, consumables, and scheduling software. The Applied Markets segment offers products in the areas of gas chromatography, mass spectrometry, spectroscopy, vacuum technology, and remarketed instruments. It markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051

800 227 9770

18000

Name Title Year Born
Mr. Michael R. McMullen CEO, Pres & Director 1961
Mr. Robert W. McMahon Sr. VP & CFO 1969
Mr. Jacob Thaysen Sr. VP and Pres of Life Sciences & Applied Markets Group 1975
Mr. Samraat S. Raha Sr. VP and Pres of Diagnostics & Genomics Group 1973
Mr. Padraig McDonnell Sr. VP & Pres of Agilent Cross Lab Group NA
Mr. Rodney Gonsalves Principal Accounting Officer, VP & Corp. Controller 1966
Dr. Darlene J. S. Solomon Ph.D. CTO & Sr. VP 1959
Mr. Michael Tang Sr. VP, Gen. Counsel & Sec. 1974
Mr. Dominique P. Grau Sr. VP of HR & Global Communications 1959
Ms. Allison Ballmer Sr. VP of Strategy & Corp. Devel. NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…